Saturday 17 October 2026
Export ZTEKF’s income statement to Excel — free account
Zentek Ltd.
ZTEKF Healthcare Medical Instruments & Supplies
Zentek Ltd.’s revenue for fiscal 2026 (year ended March 2026) was $120,200.00, down 80.8% from fiscal 2025. In the quarter to June 2026, revenue fell 95.4%, EPS was flat, free cash flow fell 254.6% and total debt rose 6.53%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.39
0.04
−9.30%
Follow ZTEKF
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
1 | 4 | 3 | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z-Score |
(2.15) | 18.17 | 34.15 | 39.31 | 59.19 | — | — | — | — | — |
P/S ratio |
467.03 | 182.31 | 4,297.12 | 0.00 | 0.00 | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(23.20) | (13.81) | (4.68) | 4.54 | 8.38 | — | — | — | — | — |
Beneish M-Score |
— | (4.60) | — | — | — | — | — | — | — | — |
P/Operating CF |
(100.21) | (121.05) | (93.82) | (64.63) | (140.22) | — | — | — | — | — |
P/B ratio |
7.91 | 10.78 | 8.13 | 6.85 | 10.19 | — | — | — | — | — |
Price to Tangible BV |
7.91 | 10.78 | 8.13 | 6.85 | 10.19 | — | — | — | — | — |
EV/Sales |
471.81 | 182.75 | 4,233.47 | (662.34) | 0.00 | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
(15.46) | (25.38) | (20.07) | (15.39) | (41.01) | — | — | — | — | — |
EV/FCF |
(23.04) | (24.65) | (18.72) | (13.09) | (27.36) | — | — | — | — | — |
Quick Ratio |
0.47 | 0.38 | 2.10 | 4.52 | 11.86 | 1.28 | 1.67 | 2.23 | 0.82 | 12.62 |
Current Ratio |
0.64 | 1.25 | 3.44 | 7.42 | 13.87 | 1.35 | 2.04 | 2.27 | 1.13 | 13.28 |
Net Debt/EBITDA |
(0.04) | (0.04) | 0.21 | 0.61 | 2.06 | 0.64 | 0.49 | 0.50 | 0.06 | 0.35 |
Debt/Assets |
11.61% | 2.76% | 4.83% | 4.45% | 5.48% | 1.36% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.18 | 0.03 | 0.05 | 0.05 | 0.06 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.52 | 0.63 | 0.69 | 0.90 | 0.21 | 0.46 | 0.88 | 0.49 | 0.64 | 0.60 |
Capex/Depreciation |
3.17 | (0.31) | (0.95) | (4.21) | (6.48) | (10.77) | (64.70) | (330.92) | (69.68) | (89.95) |
Interest Coverage |
(78.60) | (105.24) | (115.49) | (124.05) | (196.91) | (1,006.77) | (277.51) | (153.69) | (21.92) | (524.31) |
| (79.91%) | (56.47%) | (45.74%) | (43.14%) | (127.62%) | (14.61%) | (6.05%) | (10.23%) | (7.07%) | (12.85%) | |
| (58.57%) | (48.16%) | (41.39%) | (39.30%) | (115.99%) | (13.75%) | (5.91%) | (10.06%) | (7.03%) | (12.79%) | |
ROIC |
(66.94%) | (39.66%) | (43.68%) | (43.50%) | (78.87%) | (10.90%) | (4.21%) | (6.52%) | (4.66%) | (8.19%) |
Return on Tangible Assets |
(84.55%) | (73.73%) | (60.11%) | (46.69%) | (108.45%) | (13.94%) | (5.99%) | (9.75%) | (7.09%) | (12.51%) |
Average Days of Receivables |
815.94 | 503.12 | 3,630.18 | 2,851.77 | 689.81 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
995.59% | 53.37% | 5,955.66% | 2,259.89% | 444.08% | — | — | — | — | — |
Selling, General and Administrative Expense of Revenue |
3,245.92% | 821.83% | 26,695.02% | 14,048.82% | 2,647.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
756.41% | 175.35% | 5,992.31% | 4,398.19% | 1,361.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.04) | 0.00 | 0.02 | 0.07 | 0.08 | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Earnings Yield |
(14.02%) | (5.79%) | (6.61%) | (6.54%) | (11.00%) | — | — | — | — | — |
Free Cash Flow Yield |
(4.39%) | (4.07%) | (5.26%) | (7.31%) | (3.40%) | — | — | — | — | — |
Revenue per Share |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.03) | (0.04) | (0.06) | (0.10) | (0.07) | (0.02) | (0.01) | (0.01) | (0.01) | (0.02) |
Capex per Share |
0.01 | 0.00 | 0.00 | (0.02) | (0.03) | (0.01) | (0.02) | (0.02) | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.02) | (0.05) | (0.06) | (0.11) | (0.10) | (0.03) | (0.03) | (0.03) | (0.02) | (0.03) |
Cash per Share |
0.01 | 0.00 | 0.03 | 0.08 | 0.23 | 0.03 | 0.01 | 0.01 | 0.00 | 0.01 |
Shareholders Equity per Share |
0.07 | 0.10 | 0.15 | 0.22 | 0.30 | 0.25 | 0.25 | 0.28 | 0.27 | 0.28 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.07 | 0.10 | 0.15 | 0.22 | 0.30 | 0.25 | 0.25 | 0.28 | 0.27 | 0.28 |
Free Cash Flow |
(2.46) | (4.65) | (6.40) | (11.52) | (9.55) | (2.40) | (2.23) | (2.23) | (1.11) | (1.97) |
Working Capital |
(0.91) | 0.63 | 3.28 | 11.75 | 23.66 | 0.67 | 0.41 | 0.62 | 0.02 | 0.78 |
Capital Expenditures |
1.21 | (0.13) | (0.43) | (1.72) | (3.18) | (1.04) | (1.21) | (1.32) | (0.33) | (0.67) |
Net Current Asset Value |
(2.18) | 0.52 | 2.84 | 11.38 | 22.76 | 0.45 | 0.41 | 0.62 | 0.02 | 0.78 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
(10.04) | 0.21 | 19.52 | 31.21 | 11.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.04 | 0.05 | 0.04 | 0.04 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(26.46%) | (42.05%) | (34.83%) | (36.07%) | (18.92%) | (10.21%) | (11.18%) | (11.18%) | (6.40%) | (10.90%) |
Accounts Receivable Turnover |
0.21 | 1.16 | 0.07 | 0.12 | 0.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.59 | 0.33 | 0.27 | 0.67 | 0.48 | 0.50 | 0.04 | 0.01 | 0.05 | 0.11 |
Inventory Turnover |
2.86 | 0.58 | 0.15 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
662.34 | 1,591.30 | 1,289.25 | 552.90 | 1,166.88 | 694.63 | 6,554.77 | 45,467.84 | 9,154.56 | 3,177.95 |
Days of Inventory on Hand |
82.02 | 476.14 | 1,567.83 | 1,218.72 | 644.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
0.57 | 0.54 | 0.33 | 0.48 | 0.31 | 0.07 | 0.11 | 0.09 | 0.03 | 0.04 |
Average Payables |
2.29 | 1.50 | 0.92 | 0.97 | 0.62 | 0.30 | 0.40 | 0.31 | 0.09 | 0.07 |
Average Inventory |
0.47 | 0.85 | 1.60 | 1.34 | — | — | — | — | — | — |
Average Assets |
12.07 | 14.98 | 20.96 | 27.74 | 26.62 | 21.33 | 19.59 | 18.40 | 17.35 | 16.91 |
Average Common Equity |
8.85 | 12.78 | 18.97 | 25.27 | 24.19 | 20.07 | 19.15 | 18.10 | 17.26 | 16.85 |
Columns are period end dates